The 4th mRNA-Based Therapeutics Summit Europe focuses on the latest advancements in mRNA therapeutics and vaccines, highlighting key R&D opportunities, clinical data, and commercialization strategies for mRNA-based medicines.
Topics
- Visions for the Future of mRNA & Beyond: The Leadership Perspective
- Showcasing New Discoveries in mRNA Medicine From Asia to Unlock Platforms for Obesity & Antibody Production
- Deciphering a Regulatory Framework & Guidance for Future mRNA Platforms to Harmonise Clinical & Manufacturing Development
- Turbocharging new mRNA-LNP Programs to Expand Therapeutic Potential with European Research Initiatives & Collaborations
- Forging New Commercial Partnerships to Ensure Smooth Transfer into Trials & Manufacturing at Scale
- Accelerating Effective & Safe Personalised mRNA Cancer Immunotherapies Towards Clinical Success & Achieving Market Approval
- Advancing mRNA Vaccines & Therapies Towards the First Approval With Breaking First-InHuman Clinical Progress Data from Leaders in the Clinic
- Turbocharging Antigen Selection & Design to Optimise mRNA Vaccine Safety & Tolerability for Emerging Infectious Diseases
- Scale & Transfer – Leveraging Sustainable Platforms to Produce mRNA Products Effectively & Affordably for LMICs
- Achieving Effective Cell & Tissue Targeting, Distribution & Translatability with Novel LNP Formulations
- Assessing Safety, Measures & Pandemic Preparedness to Minimise Future Risks & Accelerate Response to Health Threats & Patient-Centric Decision Making
- Disruptive Companies Unlocking Diseases of Tomorrow With New Models Systems & Bioinformatic Approaches
